- Effect of Beta-glucan on intestinal anastomoses in a rat model. [Journal Article]
- CONCLUSIONS: Due to significant increases in anastomotic bursting pressures and tissue hydroxyproline levels and considering the inhibitory effect of β-Glucan on epithelial damage, edema, and submucosal-muscular layer damage, β-Glucan was thought to contribute to the healing of the anastomosis.
- FREE Publisher Full Text
- Comparison of a modified hydrocortisone/urea cream and betamethasone valerate cream in the treatment of dry eczema. [Randomized Controlled Trial]
- A half-sided, single-blind, comparative study of a new modified formulation of 1% hydrocortisone/10% urea and 0.1% betamethasone valerate cream in the treatment of dry eczema showed that the two products were equally effective at the end of 1, 2 and 3 weeks of treatment in terms of efficacy and speed of action. No statistically significant differences could be detected between either preparation …
- Contact urticaria and dermatitis to Alphaderm. [Case Reports]Contact Dermatitis. 1984 Mar; 10(3):178.CD
- Publisher Full Text
- [3-phase therapy. A contribution to the treatment of neurodermatitis atopica (endogenous eczema)]. [Journal Article]Z Hautkr. 1984 Feb 01; 59(3):157-9.ZH
- The treatment of Atopic Dermatitis in 3 periods with a double fluorated corticosteroid-carbamide-ointment, a hydrocortisone, carbamide-ointment and a carbamide-ointment without steroid will be demonstrated. This treatment shows by the base of the tachyphylaxia of the corticosteroid and the biodemand excellent results with a minimum of corticosteroid application.
- Assessment of the skin penetration properties of different carrier vehicles for topically applied cortisol. [Journal Article]
- Four commercially available topical preparations of cortisol, Alphaderm, Calmurid HC, Efcortelan and Topisone, had trace quantities of tritiated cortisol added to them. The resultant radiolabelled creams were applied to the dorsum of the pig and the penetration of the steroid was assessed. Alphaderm was shown to deliver approximately 16.0 times more cortisol to the skin than Topisone, approximate…
- Publisher Full Text
- Vasoconstrictor activities and bio-availabilities of seven proprietary corticosteroid creams assessed using a non-occluded multiple dosage regimen; clinical implications. [Journal Article]
- The bio-availabilities and activities of commercial creams (Metosyn, Synalar, Betnovate, Locoid, Alphaderm, Dioderm and Efcortelan 1%) were assessed using a multiple dosage regimen vasoconstrictor assay in ten volunteers. The blanching response first increased but then diminished with continued application over a 5-day period: following a 2-day 'resting period', when no steroid was applied, the a…
- Publisher Full Text
- A double-blind comparison of 1% hydrocortisone plus 10% urea ('Alphaderm') and 0.1% betamethasone 17-valerate in the treatment of non-infective inflammatory dermatoses. [Randomized Controlled Trial]Curr Med Res Opin. 1977-1978; 5(4):354-8.CM
- A double-blind controlled trial was carried out over a period of 3 weeks to assess the effectiveness of 1% hydrocortisone, in a specialized carbamide drug delivery system, compared with 0.1% betamethasone 17-valerate cream in the treatment of 21 patients with bilateral, symmetrical, non-infective inflammatory dermatoses. The trial preparations were applied topically twice daily, each to one side …
- Publisher Full Text
- Proprietary hydrocortisone creams. Vasoconstrictor activities and bio-availabilities of six preparations. [Journal Article]
- Six proprietary hydrocortisone creams were evaluated for vasoconstrictor activities and bio-availabilities using an occluded blanching test. Statistical analysis showed a significant difference between the formulations. Dioderm, containing 0-1% hydrocortisone, was significantly more active than the 1% hydrocortisone creams--Alphaderm, Calmurid HC, Efcortelan and Vioform-Hydrocortisone. There was …
- Publisher Full Text
- Alphaderm- hydrocortisone in a new urea base. [Journal Article]Drug Ther Bull. 1974 Dec 20; 12(26):103-4.DT